Disc Medicine, Inc.
IRON
$59.79
$0.3750.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 104.85% | 57.04% | 36.42% | 80.02% | 40.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.05% | 26.97% | 16.28% | 73.31% | 78.05% |
| Operating Income | -99.05% | -26.97% | -16.28% | -73.31% | -78.05% |
| Income Before Tax | -109.93% | -26.06% | -24.35% | -87.81% | -65.12% |
| Income Tax Expenses | -13.33% | 2,280.00% | 450.00% | 470.00% | 150.00% |
| Earnings from Continuing Operations | -109.65% | -26.48% | -24.93% | -88.35% | -65.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -109.65% | -26.48% | -24.93% | -88.35% | -65.25% |
| EBIT | -99.05% | -26.97% | -16.28% | -73.31% | -78.05% |
| EBITDA | -99.48% | -27.01% | -16.34% | -73.48% | -77.67% |
| EPS Basic | -53.53% | 5.84% | -1.82% | -52.98% | -38.43% |
| Normalized Basic EPS | -53.72% | 6.16% | 4.72% | -52.55% | -52.69% |
| EPS Diluted | -53.53% | 5.84% | -1.82% | -52.98% | -38.43% |
| Normalized Diluted EPS | -53.72% | 6.16% | 4.72% | -52.55% | -52.69% |
| Average Basic Shares Outstanding | 36.55% | 34.32% | 22.69% | 23.11% | 19.38% |
| Average Diluted Shares Outstanding | 36.55% | 34.32% | 22.69% | 23.11% | 19.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |